Avinger receives 510(k) clearance for tigereye st image-guided cto crossing system

Redwood city, ca / accesswire / april 26, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the company has received 510(k) clearance from the u.s. food & drug administration (fda) for tigereye® st, its next-generation image-guided chronic total occlusion (cto) crossing system. tigereye st expands and advances avinger's proprietary image-guided cto product line with compelling new features and benefits.
AVGR Ratings Summary
AVGR Quant Ranking